Tirzepatide vs semaglutide injection site reactions Many researchers wonder whether switching medications would eliminate injection site issues
Jafarirad S, Goodarzi R, Mohammadtaghvaei N, Dastoorpoor M, Alavinejad P
Conversely, in a recent randomized, double-blind, placebo-controlled study involving twenty healthy volunteers, a once-weekly injection of a GLP-1R agonist, dulaglutide, for three weeks did not influence HPA axis activity, showing no significant effects on circadian rhythms of blood or salivary cortisol secretion, and the level of this hormone also was not changed after the dexamethasone suppression test in comparison with the placebo-receiving group [78]
Healthcare providers take a cautious stance because of how serious the consequences of ineffective medication can be
While the injectable form of tirzepatide is widely acknowledged for its success, the search query "does tirzepatide come in pill form" may lead to unapproved and unverified compounded versions